Drug
Grn163l IN Combination With Trastuzumab
Grn163l IN Combination With Trastuzumab: highest development phase Phase 1, developed by Geron Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Geron Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| GRN163L in combination with trastuzumab NCT01265927 | Phase 1 | Breast Neoplasms |
Latest
No recent events.
Follow Grn163l IN Combination With Trastuzumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.